Besides reduced EPO production, other factors may contribute to anemia in CKD, including reduced erythrocyte life-span, hyperparathyroidism, inhibition of erythropoiesis by uremic toxins, iron metabolism disorders and impaired dietary iron and vitamin absorption [24]. Here, EPO is linked to metabolic disease.